129 related articles for article (PubMed ID: 10896229)
1. Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C.
Sauleda S; Esteban JI; Altisent C; Puig L; Esteban R; Guardia J
Thromb Haemost; 2000 Jun; 83(6):807-10. PubMed ID: 10896229
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2008 Aug; 80(8):1363-9. PubMed ID: 18551610
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
6. Sustained response to interferon-ribavirin combination therapy predicted by a model of hepatitis C virus dynamics using both HCV RNA and alanine aminotransferase.
Colombatto P; Civitano L; Oliveri F; Coco B; Ciccorossi P; Flichman D; Campa M; Bonino F; Brunetto MR
Antivir Ther; 2003 Dec; 8(6):519-30. PubMed ID: 14760885
[TBL] [Abstract][Full Text] [Related]
7. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
[TBL] [Abstract][Full Text] [Related]
8. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
9. Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients.
Santagostino E; De Filippi F; Rumi MG; Rivi M; Colombo M; Mannucci PM;
Transfusion; 2004 May; 44(5):790-4. PubMed ID: 15104664
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus RNA load in relapsed patients: week two of treatment is the best time to predict the complete response.
Halfon P; Khiri H; Tran A; Pénaranda G; Courcambeck J; Joly H; Ouzan D
Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1067-71. PubMed ID: 14501613
[TBL] [Abstract][Full Text] [Related]
11. Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa.
Fontaine H; Chaix ML; Lagneau JL; Bréchot C; Pol S
Lancet; 2000 Jul; 356(9223):41. PubMed ID: 10892765
[TBL] [Abstract][Full Text] [Related]
12. Early hepatitis C viral kinetics correlate with long-term outcome in patients receiving high dose induction followed by combination interferon and ribavirin therapy.
Rosen HR; Ribeiro RR; Weinberger L; Wolf S; Chung M; Gretch DR; Perelson AS
J Hepatol; 2002 Jul; 37(1):124-30. PubMed ID: 12076871
[TBL] [Abstract][Full Text] [Related]
13. A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers.
Rumi MG; Santagostino E; Morfini M; Gringeri A; Tagariello G; Chistolini A; Pontisso P; Tagger A; Colombo M; Mannucci PM
Blood; 1997 May; 89(10):3529-33. PubMed ID: 9160657
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers.
Schalm SW; Hansen BE; Chemello L; Bellobuono A; Brouwer JT; Weiland O; Cavalletto L; Schvarcz R; Ideo G; Alberti A
J Hepatol; 1997 May; 26(5):961-6. PubMed ID: 9186825
[TBL] [Abstract][Full Text] [Related]
15. Does a rapid decline in the hematological and biochemical parameters induced by interferon and ribavirin combination therapy for the hepatitis C virus predict a sustained viral response?
Turbide C; Soulellis C; Deschênes M; Hilzenrat N
Can J Gastroenterol; 2008 Feb; 22(2):149-52. PubMed ID: 18299740
[TBL] [Abstract][Full Text] [Related]
16. Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease.
Lethagen S; Widell A; Berntorp E; Verbaan H; Lindgren S
Br J Haematol; 2001 Apr; 113(1):87-93. PubMed ID: 11328286
[TBL] [Abstract][Full Text] [Related]
17. Depressive symptoms and physical/mental functioning with interferon/ribavirin treatment of posttransplant recurrent hepatitis C.
Bourgeois JA; Canning R; Suggett K; Chambers CC; Rahim N; Rossaro L
Psychosomatics; 2006; 47(3):254-6. PubMed ID: 16684943
[No Abstract] [Full Text] [Related]
18. Hepatitis C viral clearance and antibody reactivity patterns in persons with haemophilia and other congenital bleeding disorders.
Messick K; Sanders JC; Goedert JJ; Eyster ME
Haemophilia; 2001 Nov; 7(6):568-74. PubMed ID: 11851755
[TBL] [Abstract][Full Text] [Related]
19. [Significance of total dose of IFN in the treatment of chronic hepatitis C].
Imazeki F; Yokosuka O
Nihon Rinsho; 1994 Jul; 52(7):1794-7. PubMed ID: 7521420
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors.
Akuta N; Suzuki F; Tsubota A; Suzuki Y; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H
J Hepatol; 2002 Dec; 37(6):831-6. PubMed ID: 12445425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
